Helena Lanzafame

⁶⁸Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy

Helena Lanzafame, Ilektra A. Mavroeidi, Kim M. Pabst et al. · Journal of Nuclear Medicine · 2024 · 36 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy

Constantinos Zamboglou, Iosif Strouthos, Andrea Farolfi et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 32 citations

Medicine, Oncology, Urology +17

Diagnostic Accuracy of⁶⁸Ga-FAPI Versus¹⁸F-FDG PET in Patients with Various Malignancies

Nader Hirmas, Rainer Hamacher, Miriam Sraieb et al. · Journal of Nuclear Medicine · 2024 · 31 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis

Simon K. B. Spohn, Andrea Farolfi, Sarah Schandeler et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 30 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Artificial Intelligence Applications on Restaging [18F]FDG PET/CT in Metastatic Colorectal Cancer: A Preliminary Report of Morpho-Functional Radiomics Classification for Prediction of Disease Outcome

Pierpaolo Alongi, Alessandro Stefano, Albert Comelli et al. · Applied Sciences · 2022 · 24 citations · Full text

Medicine, Oncology, Radiology +17